Impact of Pharmacist-Led Digital Education Program on Diabetes Medication Adherence—A Large-Scale Retrospective Cohort Study in Japan
Masaya Sakamoto¹,²
1)Department of Diabetes, Metabolism & Endocrinology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
2)Department of Diabetes, Metabolism & Endocrinology, International University of Health and Welfare Narita Hospital, Chiba, Japan
Saika Tomoya ¹、Shimayoshi Shota²、Yamazaki Michiko³,¹ 、Takebe Tohru¹、Ikeda Shunya³
1) Patient Engagement Frontier Medical Science, KAKEHASHI Inc., Japan
2) Department of Machine Learning and Data Science, KAKEHASHI Inc., Japan
3)Department of Social Medical Sciences, Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
要旨
Medication adherence is essential for glycemic control but often limited by provider workload. We conducted a retrospective cohort study using Musubi pharmacy data in Japan (July–December 2023) to evaluate pharmacist-led digital Health Advice (HA). After propensity score matching, 45,721 patients were included in each group with well-balanced backgrounds. HA significantly improved adherence, with more patients achieving PDC ≥80% (OR 1.98, 95% CI 1.88–2.08). Antihypertensive and lipid-lowering therapies were also associated with higher adherence.
